Literature DB >> 8471406

Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.

R J MacFadyen1, H L Elliott, P A Meredith, J L Reid.   

Abstract

A combination of dietary sodium restriction (40 mmol day-1) and frusemide pretreatment has been used to activate the renin angiotensin system (RAS) in order to characterise the haemodynamic and hormonal responses to enalapril in young normotensives. Enalapril significantly reduced supine blood pressure with a mean maximum fall of 19 +/- 7.6, compared with 6.5 +/- 6.8 mm Hg with placebo. Similar but greater responses were seen in erect blood pressure. Mean maximal plasma ACE inhibition (78 +/- 5.7%) was associated with a significant increase in PRA from 5.2 +/- 2.1 ngAI ml-1 h-1 to a peak of 29.1 +/- 6 ngAI ml-1 h-1. This simple well tolerated regimen produced consistent RAS activation and gave readily measurable falls in blood pressure following enalapril. This model may be used to undertake detailed assessments of ACE inhibition, renin inhibition and angiotensin receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471406      PMCID: PMC1381578          DOI: 10.1111/j.1365-2125.1993.tb05697.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  The action of hydroflumethiazide in relation to adrenal steroids and potassium loss.

Authors:  C J EDMONDS; G M WILSON
Journal:  Lancet       Date:  1960-03-05       Impact factor: 79.321

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 3.  Converting-enzyme inhibitors in the treatment of hypertension.

Authors:  G H Williams
Journal:  N Engl J Med       Date:  1988-12-08       Impact factor: 91.245

4.  Enhanced renin levels after discontinuation of furosemide: additional effects of loop diuretics on renin release.

Authors:  M L Tuck; M P Sambhi; S B Kramer; P Eggena; J Barrett
Journal:  Clin Exp Hypertens A       Date:  1982

5.  Activation of inactive plasma renin by plasma and tissue kallikreins.

Authors:  F H Derkx; H L Tan-Tjiong; A J Man in 't Veld; M P Schalekamp; M A Schalekamp
Journal:  Clin Sci (Lond)       Date:  1979-10       Impact factor: 6.124

6.  Sodium intake and renal responses to captopril in normal man and in essential hypertension.

Authors:  N K Hollenberg; L G Meggs; G H Williams; J Katz; J D Garnic; D P Harrington
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

7.  The physiological disposition and metabolism of enalapril maleate in laboratory animals.

Authors:  D J Tocco; F A deLuna; A E Duncan; T C Vassil; E H Ulm
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

8.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.

Authors:  I S Anand; R Ferrari; G S Kalra; P L Wahi; P A Poole-Wilson; P C Harris
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

9.  Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.

Authors:  D Levine; L Ramsay; R Auty; R Branch; M Tidd
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Factors related to first dose hypotensive effect of captopril: prediction and treatment.

Authors:  G P Hodsman; C G Isles; G D Murray; T P Usherwood; D J Webb; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12
View more
  1 in total

1.  Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.